IntrinsicIntrinsic
← Scroll for more →

Financial Statements — SABSW

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Cash & Equivalents8.2720.5210.5029.423.695.648.909.1717.2414.0356.572.437.7713.0615.058.3316.6222.4133.21--
Short-term Investments94.3786.8786.0981.462.027.2111.8621.2320.0830.02--------------------
Accounts Receivable--------------------0.000.000.360.765.56------8.01--
Total Current Assets107.94112.78101.05113.289.3116.3023.7932.5439.5846.9558.913.139.0115.0322.1022.1827.7536.1750.190.77
Property, Plant & Equipment14.2313.8113.3113.1113.8614.6115.3716.0816.9217.9019.7420.6221.5322.3723.2524.0324.8424.9724.31--
Total Non-current Assets*130.27135.6971.7670.1720.8221.8220.4021.2622.3124.4225.0325.2126.4427.6428.8130.3331.4031.3030.95116.16
Total Assets238.21248.47172.81183.4530.1338.1244.2053.8061.8971.3783.9428.3435.4442.6750.9052.5159.1567.4781.14116.93
Accounts Payable3.863.543.152.952.622.521.691.301.171.240.951.081.401.443.685.484.944.984.46--
Total Current Liabilities11.719.8510.6810.7910.689.657.988.827.558.3010.819.2111.0113.6714.9917.1016.1418.2626.460.32
Total Non-current Liabilities*11.7211.3710.637.587.447.0610.258.088.2210.2415.833.874.724.604.854.785.907.9616.149.75
Total Liabilities23.4321.2221.3218.3718.1116.7118.2316.8915.7718.5526.6413.0815.7318.2719.8521.8822.0326.2142.5910.07
Retained Earnings(152.25)(129.76)(110.90)(94.03)(139.48)(129.37)(124.17)(112.77)(102.42)(95.09)(90.06)(67.21)(62.10)(55.22)(47.87)(40.00)(32.92)(28.14)(29.13)(9.29)
Total Stockholder Equity214.79227.25151.49165.0712.0221.4125.9736.9046.1252.8257.3015.2619.7224.4031.0630.6237.1241.2638.55(9.29)
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Total Revenue------------0.110.000.260.940.311.270.090.582.163.596.3511.8011.06--
Research & Development16.1713.4010.738.977.007.667.457.836.828.154.304.023.664.547.187.358.5813.3210.65--
Selling, General & Admin7.216.605.043.712.743.112.673.483.644.1914.882.572.903.452.844.044.315.197.75--
Total Operating Expenses23.3820.0015.7712.689.7310.7710.1211.3110.4612.3419.186.596.567.9810.0211.4012.8918.5173.570.34
Operating Income(23.38)(20.00)(15.77)(12.68)(9.73)(10.77)(10.01)(11.31)(10.20)(11.39)(18.87)(5.32)(6.48)(7.40)(7.86)(7.81)(6.54)(6.71)(12.69)(0.34)
Interest Expense----------------0.090.080.080.070.080.090.090.070.070.070.21--
Pretax Income--------------(10.35)(7.34)(5.03)(22.86)(5.10)(6.88)(7.35)(7.85)(7.08)(4.87)1.08(11.55)--
Tax Provision------------------------0.000.00----(0.09)0.09----
Net Income(22.49)(18.87)(16.86)45.45(10.11)(5.20)(11.39)(10.35)(7.34)(5.03)(22.86)(5.10)(6.88)(7.35)(7.87)(7.08)(4.78)0.99(17.58)(0.33)
Basic EPS(0.28)(0.35)1.370.50(1.09)(0.56)(1.23)(1.12)(0.79)(0.54)(7.25)(0.10)(0.14)(0.15)(0.18)(0.16)(0.11)0.02(0.41)--
Diluted EPS(0.28)(0.35)1.07(0.21)(1.09)(0.56)(1.23)(1.12)(0.79)(0.54)(7.26)(0.10)--(0.15)--(0.16)(0.11)0.02(0.41)--
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow(9.84)(14.27)(16.78)(13.05)(7.15)(7.80)(9.53)(6.29)(7.72)(10.75)(13.45)(5.17)(4.90)(1.61)0.22(8.17)(5.21)(10.29)2.54(0.09)
Capital Expenditures1.590.98--------0.060.100.050.130.070.090.020.020.120.080.611.36----
Free Cash Flow*(11.43)(15.25)--------(9.59)(6.39)(7.77)(10.88)(13.51)(5.25)(4.92)(1.63)0.10(8.25)(5.82)(11.65)----
Investing Cash Flow(4.88)(65.65)(1.71)(129.87)5.204.679.33(1.15)11.22(31.36)(0.07)(0.04)(0.02)(0.02)(0.12)(0.08)(0.61)(1.28)105.210.00
Financing Cash Flow2.3689.92(0.04)168.69(0.17)(0.17)0.22(0.67)(0.32)(0.39)67.64(0.14)(0.36)(0.36)6.62(0.03)0.03(5.56)(81.39)0.00
← Scroll for more columns →

* Derived from reported values